- 首頁
- App 分析
- Framingham CardioRisk
- Framingham CardioRisk Vs. REGICOR
Framingham CardioRisk 與 REGICOR 使用情況與統計
The Framingham Scale allows to determine the risk of suffering any cardiovascular event in 10 years, assessing factors such as age, sex, blood pressure, diabetes, and smoking, assigning a score to each of them and stratifying the patient in low, medium, and high cardiovascular risk. It also allows to calculate the vascular age, which gives an estimate of the vascular damage of the patient through the variation of years between it and its chronological age.
Made for healthcare professionals.
Do not use for self-diagnosis. Seek a doctor’s advice.
- Apple App Store
- 免費版
- 醫療
商店排名
- -
The REGICOR study researchers have developed an adaptation of the Framingham tables, calibrated for their use with Spanish population.
These tables have been adapted to the characteristics of the Spanish population [5-6] through a well contrasted calibration process [1-4]. They allow the estimation of coronary events (angina, heart attack with or without symptoms, deadly or not) in 10 years.
They have been adapted through a well-proven calibration process and an HTML application has been programmed to allow the estimation of coronary events in 10 years. It is also possible to print the results with some heart-healthy tips.
You may know what is the likelihood of suffering a heart attack or angina in the next 10 years. Since atherosclerosis can affect all the arteries of the human body, this estimate can be made available to other events such as stroke, although the precision of the result is lower.
If you're between 35 and 74 years and want to calculate their risk, a simple program will seek the necessary information. The risk calculator requires 8 data to give a result. Firstly, sex, age, smoker or not and if you are diabetic or not. Second, data on levels of systolic and diastolic blood pressure. Finally, the values of total cholesterol and HDL cholesterol from your blood test comes later.
You can also add if you have been diagnosed of Human Immunodeficiency Virus (HIV), or if you suffer from a Myeloproliferative Neoplasm such as Polycythemia Vera or Essential Thrombocythemia.
The result of the cardiovascular risk assessment performed with REGICOR should be interpreted in the appropriate clinical context. Do not make any preventive decisions without consulting your doctor, to whom you should show the results of your REGICOR score. Only your doctor can decide how to handle your cardiovascular risk.
- Apple App Store
- 免費版
- 醫療
商店排名
- -
Framingham CardioRisk與 REGICOR 比較排名
比較過去 28 天的 Framingham CardioRisk 排名趨勢與 REGICOR
排名
無可用數據
各國 Framingham CardioRisk vs. REGICOR 排名比較
比較過去 28 天的 Framingham CardioRisk 排名趨勢與 REGICOR
無可顯示數據
使用我們的免費試用版,與所有網站進行比較
Framingham CardioRisk VS.
REGICOR
1月 4, 2025